ETM
OME

Euclidean Technologies Management’s Omega Protein OME Stock Holding History

Euclidean Technologies Management’s Portfolio OME Stock Details OME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-65,153
Closed -$1.08M – 63
2017
Q3 		$1.08M Hold
65,153
– – 1.04% 51
2017
Q2 		$1.17M Sell
65,153
-2,300
-3% -$43K 1.12% 48
2017
Q1 		$1.35M Buy
+67,453
New +$1.57M 1.25% 50
2014
Q4 		– Sell
-245,910
Closed -$3.07M – 48
2014
Q3 		$3.07M Buy
245,910
+197,462
+408% +$2.75M 2.86% 25
2014
Q2 		$663K Buy
+48,448
New +$633K 0.59% 36

Euclidean Technologies Management's OME Position: Q4 2017 in Review

Euclidean Technologies Management sold out of Omega Protein (OME) in Q4 2017, closing a stake of 65,153 shares — an estimated $1.08M sold.

Euclidean Technologies Management first reported a position in OME in Q2 2014 and held it in 5 quarters. The position peaked at $3.07M in Q3 2014. 0 funds tracked by Wall St. Rank hold OME as of Q4 2017.

  • Euclidean Technologies Management reported no remaining Omega Protein position as of Q4 2017 after selling out during the quarter.
  • Euclidean Technologies Management sold 65,153 Omega Protein shares in Q4 2017, an estimated $1.08M.
  • Euclidean Technologies Management first reported a position in Omega Protein in Q2 2014 and held it in 5 quarters.
  • Euclidean Technologies Management's Omega Protein position peaked at $3.07M in Q3 2014.
  • 0 funds tracked by Wall St. Rank held Omega Protein as of Q4 2017.

Based on Euclidean Technologies Management's 13F filing for Q4 2017, filed 14 Feb 2018.